AdministrativeAnthem Blue Cross and Blue Shield | CommercialSeptember 1, 2023

Consider a FIT kit for your patients aged 45 and older at average risk for colon cancer

The American Cancer Society (ACS) recommends annual fecal immunochemical test (FIT) kit testing for all adults aged 45 and older with average risk for colon cancer. For these patients, the FIT kit is a convenient, cost-effective, and discreet testing option.1, 2

FIT kits offer a cost-effective, highly accurate option for colorectal cancer screening

Screening with FIT kits is convenient and easier than ever. Adopting FIT screening into your practice can help increase patient adherence to colon cancer screening recommendations. Annual FIT improves screening rates and has also been shown to save lives.3

Anthem Blue Cross and Blue Shield network physicians and their patients have access to high-quality, low-cost colorectal cancer screening FIT kits through our National Lab partners Labcorp and Quest Diagnostics.* If you have specific questions, please contact the labs directly:

To find Labcorp, Quest Diagnostics, and other participating labs in your patient’s plan network, select Find Care from the Provider Resources menu at anthem.com.

References:
1. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.CA Cancer J Clin.2018;68(4):250-281.
2. Occult blood, fecal, immunoassay. Laboratory Corporation of America Holdings and Lexi-Comp Inc. 2021. Accessed April 11, 2022. https://bit.ly/3pRHPlV.
3. Dougherty MK, Brenner AT, Crockett SD, et al. Evaluation of interventions intended to increase colorectal cancer screening rates in the United States: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(12):1645-1658.

* Quest Diagnostics is an independent company providing preventive care technology and health risk assessments services on behalf of the health plan.

MULTI-BCBS-CM-024720-23-CPN24527, MULTI-BCBS-CM-034185-23

PUBLICATIONS: June 2023 Provider Newsletter, September 2023 Provider Newsletter